anastrozole has been researched along with Erythema Multiforme in 2 studies
Erythema Multiforme: A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic bull's-eye lesions usually occurring on the dorsal aspect of the hands and forearms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Anastrozole, a nonselective aromatase inhibitor used in breast cancer management has been associated with different cutaneous side effects, of which EM is rarely seen and usually in a minor or major form with typical target lesions." | 8.31 | Segmental Erythema Multiforme: An Unusual Drug Reaction to Anastrozole. ( Buljan, M; Filipović, N; Poduje, S; Vučić, M; Vujević, L, 2023) |
| " Anastrozole, a nonselective aromatase inhibitor used in breast cancer management has been associated with different cutaneous side effects, of which EM is rarely seen and usually in a minor or major form with typical target lesions." | 4.31 | Segmental Erythema Multiforme: An Unusual Drug Reaction to Anastrozole. ( Buljan, M; Filipović, N; Poduje, S; Vučić, M; Vujević, L, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Poduje, S | 1 |
| Vujević, L | 1 |
| Filipović, N | 1 |
| Vučić, M | 1 |
| Buljan, M | 1 |
| Nakatani, K | 1 |
| Matsumoto, M | 1 |
| Ue, H | 1 |
| Nishioka, A | 1 |
| Tanaka, Y | 1 |
| Kodama, H | 1 |
| Sasaguri, S | 1 |
| Ogawa, Y | 1 |
2 other studies available for anastrozole and Erythema Multiforme
| Article | Year |
|---|---|
Segmental Erythema Multiforme: An Unusual Drug Reaction to Anastrozole.
Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Drug Eruptions; Erythema Multiforme; Female; Hu | 2023 |
Erythema multiforme after radiotherapy with aromatase inhibitor administration in breast-conservation treatment for breast cancer.
Topics: Administration, Oral; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Combined Modality Therapy | 2008 |